Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

According to BIS Research, Antibody Conjugate Oligonucleotides (ACOs) combine the gene-modulating properties of ...

Oligo Factory, a leading science-driven provider of high-quality custom DNA and RNA oligonucleotides for therapeutic, ...

A new specialist manufacturing facility in Scotland could soon provide solutions to scaling challenges for vital ...

Codexis reiterated its full-year 2025 financial guidance originally issued on February 27, 2025, as follows: Total revenues are expected to be in the range of $64 million to $68 million.

The partnership between Asahi Kasei Bioprocess America and PeptiSystems will extend globally across all relevant markets, ...

A Deep Dive into Key Projections and Future Opportunities. The DNA synthesis market continues to witness significant growth, driven by advancements in biotechnology and increased demand for synthetic ...

In addition, three leading contract development and manufacturing organizations (CDMOs) are presenting data on the performance of Codexis’ double-stranded RNA ligases to combine short RNA fragments, ...

This manuscript characterizes a mutated clone of RNA polymerase I in yeast, referred to as SuperPol, to understand the mechanisms of RNA polymerase I elongation and termination. The authors present ...